Kilitch Drugs (India) Limited — Others, 26-08-2025: Copy of Newspaper Publication

Kilitch Drugs (India) Limited has completed its Rights Issue, allotting 13,98,463 fully paid-up Equity Shares at ₹357.00 per share. The issue successfully raised ₹49.93 Crore. The Rights Issue, offered at a ratio of 2 shares for every 23 held, was oversubscribed with valid applications for 118.20% of the issue size. Shares are expected to be credited to Demat accounts and commence trading around August 26, 2025, boosting the company's capital.